NovaBay Pharmaceuticals (NBY) Posts Break Even Q3 Loss
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $1.95 --0%
Financial Fact:
Income (loss) before income taxes: -3.74M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Income (loss) before income taxes: -3.74M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
NovaBay Pharmaceuticals (NYSE: NBY) reported Q3 EPS of $0.00, $0.04 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $3.64 million versus the consensus estimate of $3.08 million.
For earnings history and earnings-related data on NovaBay Pharmaceuticals (NBY) click here.
For earnings history and earnings-related data on NovaBay Pharmaceuticals (NBY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
- Laird Superfood, Inc. (LSF) Misses Q2 EPS by 22c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
